Martingale Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-24,100	Closed	-$175K	–	828
2022 Q2	$175K	Buy	+24,100	New	+$175K	﹤0.01%	813
2020 Q2	–	Sell	-42,712	Closed	-$693K	–	1027
2020 Q1	$693K	Buy	+42,712	New	+$693K	0.01%	752